Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Rogenhofer

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Prostate|September 10, 2009
Global levels of histone modifications predict prostate cancer recurrenceJörg Ellinger, Philip Kahl, Johannes von der Gathen, et al.
BMC Urology|March 15, 2012
Alterations of global histone H4K20 methylation during prostate carcinogenesisTurang E Behbahani, Philip Kahl, Johannes von der Gathen, et al.
European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
The Journal of Pediatrics|June 18, 2011
Phenotype severity in the bladder exstrophy-epispadias complex: analysis of genetic and nongenetic contributing factors in 441 families from North America and EuropeHeiko Reutter, Simeon A Boyadjiev, Lisa Gambhir, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Prostate|September 10, 2009
Global levels of histone modifications predict prostate cancer recurrenceJörg Ellinger, Philip Kahl, Johannes von der Gathen, et al.
BMC Urology|March 15, 2012
Alterations of global histone H4K20 methylation during prostate carcinogenesisTurang E Behbahani, Philip Kahl, Johannes von der Gathen, et al.
European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
The Journal of Pediatrics|June 18, 2011
Phenotype severity in the bladder exstrophy-epispadias complex: analysis of genetic and nongenetic contributing factors in 441 families from North America and EuropeHeiko Reutter, Simeon A Boyadjiev, Lisa Gambhir, et al.
Pageof 4